Header

UZH-Logo

Maintenance Infos

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis


Schernthaner, G; Barnett, A H; Betteridge, D J; Carmena, R; Ceriello, A; Charbonnel, B; Hanefeld, M; Lehmann, R; Malecki, M T; Nesto, R; Pirags, V; Scheen, A; Seufert, J; Sjohölm, A; Tsatsoulis, A; DeFronzo, R (2010). Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia, 53(7):1258-1269.

Abstract

The ADA and the EASD recently published a consensus statement for the medical management of hyperglycaemia in patients with type 2 diabetes. The authors advocate initial treatment with metformin monotherapy and lifestyle modification, followed by addition of basal insulin or a sulfonylurea if glycaemic goals are not met (tier 1 recommendations). All other glucose-lowering therapies are relegated to a secondary (tier 2) status and only recommended for selected clinical settings. In our view, this algorithm does not offer physicians and patients the appropriate selection of options to individualise and optimise care with a view to sustained control of blood glucose and reduction both of diabetes complications and cardiovascular risk. This paper critically assesses the basis of the ADA/EASD algorithm and the resulting tiers of treatment options.

Abstract

The ADA and the EASD recently published a consensus statement for the medical management of hyperglycaemia in patients with type 2 diabetes. The authors advocate initial treatment with metformin monotherapy and lifestyle modification, followed by addition of basal insulin or a sulfonylurea if glycaemic goals are not met (tier 1 recommendations). All other glucose-lowering therapies are relegated to a secondary (tier 2) status and only recommended for selected clinical settings. In our view, this algorithm does not offer physicians and patients the appropriate selection of options to individualise and optimise care with a view to sustained control of blood glucose and reduction both of diabetes complications and cardiovascular risk. This paper critically assesses the basis of the ADA/EASD algorithm and the resulting tiers of treatment options.

Statistics

Citations

Dimensions.ai Metrics
74 citations in Web of Science®
89 citations in Scopus®
85 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 09 Feb 2011
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Endocrinology and Diabetology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2010
Deposited On:09 Feb 2011 19:04
Last Modified:17 Feb 2018 18:29
Publisher:Springer
ISSN:0012-186X
OA Status:Closed
Publisher DOI:https://doi.org/10.1007/s00125-010-1702-3
PubMed ID:20352408

Download